caffeine has been researched along with methoxsalen in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brogger, A; Stene, J; Waksvik, H | 1 |
| Clarke, CH; Wade, MJ | 1 |
| Apseloff, G; Gerber, N; Hilliard, JB; Mays, DC | 1 |
| Gerber, N; Hilliard, JB; Mays, DC; Nawoot, S; Pacula, CM | 1 |
| Camisa, C; Cheney, P; Gerber, N; Mays, DC; Nawoot, S; Pacula, CM | 1 |
| Sasaki, MS; Tonomura, A | 1 |
| Gillies, NE; Marshall, NJ; Panchapagesan, G | 1 |
| Clarke, CH; Godsell, AM | 1 |
| Ashwood-Smith, MJ; Grant, E | 1 |
| Agache, P; Bechtel, PR; Bechtel, Y; Bendriss, A; Bendriss, EK; Humbert, PH; Magnette, J; Paintaud, G | 1 |
| Gniazdowski, M; Małagocka, E; Tołwińska-Stańczyk, Z; Wilmańska, D | 1 |
| Fuhr, U; Scharffetter-Kochanek, K; Servera-Llaneras, M; Tantcheva-Poór, I | 1 |
| Szeto, YT; Tong, HH | 1 |
1 review(s) available for caffeine and methoxsalen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for caffeine and methoxsalen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Psoralen/UVA treatment and chromosomes. I. Aberrations and sister chromatid exchange in human lymphocytes in vitro and synergism with caffeine.
Topics: Caffeine; Chromatids; Chromosome Aberrations; Chromosomes, Human; Coumarins; Drug Synergism; Female; Humans; Methoxsalen; Time Factors; Trioxsalen; Ultraviolet Rays | 1977 |
Evidence that caffeine, 8-methoxypsoralen and steroidal diamines are frameshift mutagens for E. coli K-12.
Topics: Caffeine; Culture Media; Diamines; Escherichia coli; Genetic Code; Hycanthone; Methoxsalen; Mutagens; Mutation; Quinacrine; Transcription, Genetic | 1975 |
Inhibition and induction of drug metabolism by psoralens: alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice.
Topics: Animals; Caffeine; Coumarins; Furocoumarins; Half-Life; Hexobarbital; Male; Methoxsalen; Mice; Sleep; Time Factors; Warfarin | 1991 |
Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
Topics: Animals; Biotransformation; Caffeine; Hexobarbital; Male; Methoxsalen; Phenytoin; Rats; Rats, Inbred Strains | 1987 |
Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans.
Topics: Adult; Biotransformation; Caffeine; Female; Humans; Male; Metabolic Clearance Rate; Methoxsalen; Middle Aged; Psoriasis; PUVA Therapy | 1987 |
A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents.
Topics: Alkanesulfonates; Alkylating Agents; Anemia, Aplastic; Antimetabolites; Caffeine; Cell Division; Cells, Cultured; Chloramphenicol; Chromosome Aberrations; Chromosomes; Cobalt Isotopes; Dactinomycin; DNA Repair; Humans; Lymphocytes; Mechlorethamine; Methoxsalen; Mitomycins; Nitrosoguanidines; Quinolines; Radiation Effects; Ultraviolet Rays | 1973 |
Rescue by chloramphenicol and rifampicin of UV-irradiated lon, exrA and recA mutants of Escherichia coli K12.
Topics: Caffeine; Cell Survival; Chloramphenicol; Escherichia coli; Methoxsalen; Mutation; Radiation Effects; Rifampin; Ultraviolet Rays | 1973 |
Response of phage T5 to host cell reactivation.
Topics: Caffeine; Coliphages; DNA Nucleotidyltransferases; DNA Repair; DNA Viruses; DNA, Viral; Escherichia coli; Genes; Genetic Variation; Hot Temperature; Methoxsalen; Mutation; Radiation Effects; Ultraviolet Rays | 1973 |
Effect of temperature on dose-dependent changes in sedimentation characteristics of bacterial DNA produced, in vivo, by near-ultraviolet irradiation and 8-methoxypsoralen.
Topics: Bacterial Proteins; Caffeine; Cell Membrane; Cell Survival; Centrifugation, Density Gradient; Crossing Over, Genetic; DNA Repair; DNA, Bacterial; Dose-Response Relationship, Radiation; Escherichia coli; Freezing; Methoxsalen; Mutation; Photochemistry; RNA, Bacterial; Temperature; Ultraviolet Rays | 1974 |
Inhibition of caffeine metabolism by 5-methoxypsoralen in patients with psoriasis.
Topics: 5-Methoxypsoralen; Adult; Aged; Caffeine; Central Nervous System Stimulants; Female; Humans; Male; Methoxsalen; Middle Aged; Psoriasis | 1996 |
Photoreaction of furocoumarins with DNA is similarly inhibited by minor and major groove-interacting ligands.
Topics: Animals; Caffeine; Cattle; DNA; Methoxsalen; Methyl Green; Netropsin; Photochemistry; Proflavine | 1997 |
Liver cytochrome P450 CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Baths; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Female; Humans; Liver; Male; Methoxsalen; Middle Aged; PUVA Therapy; Skin Diseases | 2001 |
Caffeine as a photoprotective agent for diminishing phototoxicity.
Topics: 5-Methoxypsoralen; Caffeine; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Humans; Lymphocytes; Methoxsalen; Photosensitizing Agents; Protective Agents | 2010 |